Seres Therapeutics is a late-clinical-stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome. Read More Recent...
Seres’ visionary team has been at the forefront of microbiome therapeutics for over a decade. Discover our mission, leadership, partners, and more.
马萨诸塞州剑桥--(美国商业资讯)--2024年2月26日--领先的微生物组治疗公司Seres Therapeutics, Inc.(纳斯达克股票代码:MCRB)今天宣布,在大卫·阿科维茨退休后,玛瑞拉·索雷尔将从3月25日起加入执行副总裁兼首席财务官(CFO)。阿科维茨先生自2021年6月起担任首席财务官,并将随时协助过渡。 Ms. Thorell is ...